Greg Goldmacher

Greg Goldmacher is a distinguished leader in clinical research with extensive experience in medical and scientific strategy, particularly in clinical imaging and pathology across various therapeutic areas, including oncology and CNS. From January 2019 to March 2023, Greg served as Associate VP at Merck, directing a team responsible for over 300 clinical trials and contributing to more than 50 regulatory approvals. As a co-founder of MedCoShare, Greg has played a pivotal role in establishing innovative healthcare services for independent providers since January 2019. Prior roles include Senior Director at ICON plc and various positions at Thomas Jefferson University Hospitals and Massachusetts General Hospital, where Greg focused on advanced imaging and stem cell research. Academically, Greg holds an MD, PhD in Medicine/Neuroscience from UT Southwestern Medical Center and an MBA from Fox School of Business at Temple University.